Insiders Ipsen

Equities

Market Closed - Euronext Paris Other stock markets 09:05:05 21/06/2024 pm IST			5-day change	1st Jan Change
113.9 ^EUR	-2.57%		-5.48%	+5.56%

12/06	Ipsen: share price soars, UBS confirms its recommendation	CF
12/06	IPSEN : UBS remains Buy after FDA approval	CF

Ipsen Hires New Chief Corporate Affairs Officer	06/06	MT
Ipsen: new Chief Corporate Affairs Officer	06/06	CF
Ipsen Announces Executive Changes	02/05	CI
Ipsen: new President for North America	02/05	CF
Ipsen: appointment of an independent director	04/23/04	CF
Ipsen appoints new R&D Director	01/23/01	CF
Ipsen appoints new Medical Director	24/23/24	CF
France's Ipsen Names Chief Medical Officer	24/23/24	MT
Ipsen Appoints Sandra Silvestri as EVP, Chief Medical Officer and Head of Global Medical Affairs, Patient Safety and Patient Affairs, Effective 5 May 2023	24/23/24	CI
Lysogene: interim CFO confirmed	06/23/06	CF
Cann Group Appoints CEO	10/23/10	MT
OSE Immunotherapeutics Appoints Ipsen Executive As CEO	14/22/14	MT
Ipsen Appoints Catherine Abi-Habib as EVP Strategy, Transformation, and Digital	16/22/16	CI
Ipsen Nominates Karen Witts as New Independent Board Member	21/22/21	CI
Ipsen Appoints Stewart Campbell as Executive Vice President and President of North America	03/21/03	CI
Ipsen Appoints Mari Scheiffele as EVP and President, Specialty Care International, Effective November 1, 2021	11/21/11	CI
Mirati Therapeutics : taps industry veteran Meek as CEO	20/21/20	RE
Karyopharm Therapeutics : Reports Narrower Q1 Loss, Higher Revenue, Names Richard Paulson as New CEO	03/21/03	MT
Ipsen Appoints Gwenan White as Executive Vice President Communications and Public Affairs	21/21/21	CI
Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer	25/20/25	CI

No results for this search

IPSEN : Better-than-expected Q1; guidance unchanged

April 24, 2024 at 08:20 pm IST